BBA

Baker Bros. Advisors Portfolio holdings

AUM $17.1B
1-Year Est. Return 139.98%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+139.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.1B
AUM Growth
+$3.24B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
100
New
Increased
Reduced
Closed

Top Buys

1
+$135M
2
+$92.2M
3
+$81.4M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$60.9M
5
ALKS icon
Alkermes
ALKS
+$57.5M

Top Sells

1
+$54.1M
2
+$47.4M
3
+$39M
4
RNAM
Avidity Biosciences
RNAM
+$27.2M
5
PCVX icon
Vaxcyte
PCVX
+$23.1M

Sector Composition

1 Healthcare 99.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPCR icon
26
Structure Therapeutics
GPCR
$3.77B
$99.6M 0.58%
1,432,529
-123,580
ABCL icon
27
AbCellera Biologics
ABCL
$1.14B
$94.1M 0.55%
27,525,640
NRIX icon
28
Nurix Therapeutics
NRIX
$1.69B
$88.4M 0.52%
4,658,556
+776,431
IMCR icon
29
Immunocore
IMCR
$1.57B
$80.6M 0.47%
2,322,656
BCYC
30
Bicycle Therapeutics
BCYC
$344M
$77.1M 0.45%
10,885,357
CRNX icon
31
Crinetics Pharmaceuticals
CRNX
$4.16B
$76.8M 0.45%
1,648,869
+1,368,869
GLUE icon
32
Monte Rosa Therapeutics
GLUE
$1.4B
$68.1M 0.4%
4,345,736
-570,359
RARE icon
33
Ultragenyx Pharmaceutical
RARE
$2.42B
$63.8M 0.37%
2,772,692
DNLI icon
34
Denali Therapeutics
DNLI
$3.2B
$61.6M 0.36%
3,731,695
VRDN icon
35
Viridian Therapeutics
VRDN
$1.55B
$61.4M 0.36%
1,971,678
+227,272
TRDA icon
36
Entrada Therapeutics
TRDA
$517M
$52.1M 0.31%
5,072,730
+206,911
RAPP
37
Rapport Therapeutics
RAPP
$1.63B
$46.9M 0.27%
1,547,090
TERN icon
38
Terns Pharmaceuticals
TERN
$6.07B
$38.4M 0.22%
+950,000
BNTX icon
39
BioNTech
BNTX
$24.9B
$35.1M 0.21%
368,923
SYRE icon
40
Spyre Therapeutics
SYRE
$5.03B
$32.8M 0.19%
1,000,000
DNTH icon
41
Dianthus Therapeutics
DNTH
$5.17B
$32.5M 0.19%
789,759
PRLD icon
42
Prelude Therapeutics
PRLD
$257M
$29.4M 0.17%
10,123,824
DBVT
43
DBV Technologies
DBVT
$1.28B
$28M 0.16%
1,461,425
IRON icon
44
Disc Medicine
IRON
$2.69B
$26.8M 0.16%
337,050
JBIO
45
Jade Biosciences
JBIO
$959M
$25.3M 0.15%
+1,641,137
TSHA icon
46
Taysha Gene Therapies
TSHA
$1.35B
$22M 0.13%
4,004,756
BCRX icon
47
BioCryst Pharmaceuticals
BCRX
$2.43B
$22M 0.13%
+2,822,727
VTYX
48
DELISTED
Ventyx Biosciences
VTYX
$21.2M 0.12%
2,349,280
+1,326,150
ARGX icon
49
argenx
ARGX
$49.7B
$21.2M 0.12%
25,174
-12,586
DSGN icon
50
Design Therapeutics
DSGN
$750M
$20.9M 0.12%
2,233,099
+520,217
1
2
3 4